| GTO ID | GTC1409 |
| Trial ID | NCT01517464 |
| Disease | Solid Tumor |
| Altered gene | RB94 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | SGT-94 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors |
| Year | 2012 |
| Country | United States |
| Company sponsor | SynerGene Therapeutics, Inc. |
| Other ID(s) | SGT94-01 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||